Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
for
Prostate Cancer, Prostate Cancer (Adenocarcinoma),
Location: Boston MA
Sponsor: Shehzad Basaria, M.D.
Sex: Male
Age: 40+
Code: NCT06957691
Phase2, Recruiting
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
for
Metastatic Breast Cancer, HER2-negative Breast Cancer,
Location: Omaha NE
Sponsor: RayzeBio, Inc.
Sex: All
Age: 0+
Code: NCT06590857
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
for
Phase 1, NK Cell, IL13Ra, EGFRvIII,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07579208
Phase1, Recruiting
A Study of VV-14305 for the Treatment of Thyroid Eye Disease
for
Thyroid Eye Disease (TED)
Location: Erie PA, Livonia MI, Las Vegas NV
Sponsor: Kriya Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07404111
Phase1, Phase2, Recruiting
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
for
HER2-negative Breast Cancer, Hormone Receptor Positive Tumor,
Location: Port Huron MI, Mount Clemens MI, Detroit MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 22+
Code: NCT07227831
Recruiting
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
for
High Grade Neuroendocrine Neoplasms
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT06926634
Phase2, Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
for
Melanoma (Skin Cancer),
Location: Lake Success NY, Fairfax VA, Detroit MI, Cincinnati OH,
Sponsor: Aminex Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07287917
Phase1, Phase2, Recruiting
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study Participants
for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women
Location: Mount Royal
Sponsor: Bayer
Sex: Female
Age: 18 - 65
Code: NCT07762287
Phase1, Recruiting
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
for
Thyroid Eye Disease, TED, Graves Orbitopathy
Location: Las Vegas NV
Sponsor: Sling Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07753603
Phase3, Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Toronto, Knoxville TN, Atlanta GA, Nashville TN,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07544654
Phase3, Recruiting
A Study to Evaluate the Effects of a Prebiotic Soda on Glycemic Control in Adults
for
Blood Glucose Control
Location: Los Angeles CA
Sponsor: Olipop, PBC
Sex: All
Age: 30 - 70
Code: NCT07298135
Recruiting
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: Female
Age: 18 - 50
Code: NCT07460752
Phase2, Recruiting
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
for
HER2 Low Breast Carcinoma, Triple Negative Breast Cancer,
Location: San Francisco CA
Sponsor: Laura Huppert, MD, BA
Sex: All
Age: 18+
Code: NCT06224673
Phase2, Recruiting
Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study
for
Lymphoma Receiving CAR-T Therapy
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07509450
Recruiting
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
for
Thyroid Eye Disease
Location: Morgantown WV, Kissimmee FL, Orland Park IL,